Published in J Clin Endocrinol Metab on September 01, 1992
Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery. Int J Pediatr Endocrinol (2011) 1.13
Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child (1996) 1.09
Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment. Eur J Pediatr (2006) 0.83
Fertility Preservation in Women with Turner Syndrome: A Comprehensive Review and Practical Guidelines. J Pediatr Adolesc Gynecol (2015) 0.78
Williams Syndrome and 15q Duplication: Coincidence versus Association. Mol Syndromol (2016) 0.75
A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology (2004) 4.24
Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. I. Clinical evaluation of the syndrome. N Engl J Med (1967) 2.89
Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) (1981) 2.66
Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.57
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab (1996) 2.37
The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol (1966) 2.34
Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology (1996) 2.28
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med (1994) 2.06
Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev (1998) 2.05
Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest (1996) 1.97
Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.95
Gonadotropin-releasing hormone and its analogues. N Engl J Med (1991) 1.94
Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med (1982) 1.89
Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab (2000) 1.84
Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab (1999) 1.83
Clinical and genetic heterogeneity in idiopathic Addison's disease and hypoparathyroidism. J Clin Endocrinol Metab (1968) 1.78
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.76
Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med (2000) 1.74
A clinical trial of creatine in ALS. Neurology (2004) 1.73
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology (2006) 1.73
The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res (1985) 1.71
Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med (1992) 1.69
Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol (1993) 1.67
Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility. N Engl J Med (1997) 1.66
Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab (2001) 1.65
Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2001) 1.65
The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol (1967) 1.64
Gonadotropin-releasing hormone and its analogs. Annu Rev Med (1994) 1.61
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab (1987) 1.58
Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr Rev (1986) 1.56
The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab (2001) 1.56
CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome. Clin Genet (2008) 1.56
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys (1980) 1.50
The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh) (1986) 1.46
A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr (1970) 1.46
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod (1999) 1.45
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab (2006) 1.41
The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. J Clin Endocrinol Metab (1998) 1.41
Nonsurgical treatment of aggressive fibromatosis in the head and neck. Otolaryngol Head Neck Surg (1989) 1.39
Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab (2006) 1.38
Local reactions to depot leuprolide therapy for central precocious puberty. J Pediatr (1993) 1.36
A comparison of the effects of insulin hypoglycaemia and arginine infusion on release of human growth hormone. Lancet (1967) 1.34
The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab (1996) 1.33
Correlation of serum follicular stimulating hormone (FSH) and luteinizing hormone (LH) as measured by radioimmunoassay in disorders of sexual development. J Clin Invest (1970) 1.31
Global self-ratings of health and mortality: hazard in the North Carolina Piedmont. J Clin Epidemiol (1996) 1.30
Coexistence of diabetes mellitus and insipidus and optic atrophy in two male siblings. Studies and review of literature. Am J Med (1970) 1.29
Hypertrophic cardiomyopathy in total lipodystrophy. J Pediatr (1986) 1.29
Candidiasis: studies pertaining to its association with endocrinopathies and pernicious anemia. Pediatrics (1968) 1.28
Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2006) 1.27
Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. II. Endocrinologic evaluation of the syndrome. N Engl J Med (1967) 1.27
The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab (2001) 1.26
Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab (1969) 1.25
Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab (1986) 1.24
Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med (1987) 1.23
Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab (1987) 1.23
Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies. J Clin Endocrinol Metab (1999) 1.22
Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J Clin Endocrinol Metab (1980) 1.22
A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol (1983) 1.19
Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (1989) 1.18
X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab (1999) 1.17
The use of statistical MUNE in a multicenter clinical trial. Muscle Nerve (2004) 1.17
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab (1981) 1.17
Accuracy and reproducibility of clinical measures of testicular volume. J Pediatr (1987) 1.17
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. N Engl J Med (1981) 1.16
Alopecia areata. Immunologic studies and treatment with prednisone. Arch Dermatol (1973) 1.15
Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol (1988) 1.15
Functional outcome measures as clinical trial endpoints in ALS. Neurology (2004) 1.15
Evidence for the placental transfer of tri-iodothyronine in human beings. N Engl J Med (1967) 1.14
A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J Clin Endocrinol Metab (1997) 1.14
Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab (2000) 1.14
Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab (1988) 1.14
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocr Rev (1986) 1.13
Translational careers. Science (2009) 1.13
Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents. J Pediatr (1977) 1.12
Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab (2001) 1.12
Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest (1984) 1.12
Kisspeptin and GPR54: discovery of a novel pathway in reproduction. J Neuroendocrinol (2008) 1.12
Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency. J Clin Invest (1972) 1.12
Growth in female gymnasts: should training decrease during puberty? J Pediatr (1993) 1.11
Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr (1993) 1.11
Micropenis. I. Criteria, etiologies and classification. Johns Hopkins Med J (1980) 1.11
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer (1983) 1.10
Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet (1986) 1.10
Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. N Engl J Med (1983) 1.10
The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (2000) 1.09
Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors. J Clin Endocrinol Metab (1994) 1.08